We provide the latest news
from the world of economics and finance$180,000 of DANAHER CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081 Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy
General issues related to antitrust laws
General issues related to permanent normal trade relations"
You can find more data on corporate lobbying on Quiver Quantitative.
DHR insiders have traded $DHR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
We have seen 952 institutional investors add shares of DHR stock to their portfolio, and 991 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.